Total Funding
65
62
Total FundingPost-IPO Equity raised
Growth Score
3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
9375
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
- Lisa von Moltke: Head of Research and Development and Chief Medical OfficerPast Role: Seres Therapeutics, Executive Vice President and Chief Medical Officer
- Hua Mu: Chief Executive Officer
About the Company
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.
